PHOENIX, Feb. 28,
2023 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES,
"SenesTech" or the "Company"), (www.senestech.com) the rodent
fertility control experts and inventors of the only EPA registered
contraceptive for male and female rats, ContraPest®,
today announced that more details of ContraPest's efficacy were
reported from multiple sources at the latest Vertebrate Pest
Conference (VPC). The minutes from the VPC conference were recently
released.
In one paper, SenesTech researchers reported on a dramatic 95%
reduction of rat activity when ContraPest was added to the existing
integrated pest management (IPM) program. Results showed that as
ContraPest consumption increased over the study, rat activity
significantly declined.
"In addition to the scientific evidence presented, we also heard
from customers that they experienced lower losses and economic
costs," said Nicole Williams,
SenesTech's Chief Revenue Officer.
In other papers and discussions at VPC, independent studies and
results included:
- A 98% rat population reduction in an animal rescue facility on
the west coast,
- An 80% rat population reduction at a second animal rescue
facility, also on the west coast, and
- A 90% rat population reduction in an urban setting in
Seattle.
"As more and more customers incorporate ContraPest into their
IPM programs, more and more customers are reporting dramatic
efficacy, and, in the case of agribusiness customers, economic
benefit. This surge of acceptance will be key to building on our
growth trend and even accelerating it in 2023," said Joel Fruendt, SenesTech's CEO.
The Company's paper at VPC can be accessed here:
https://escholarship.org/uc/item/72f1b8bj
About SenesTech
We are the experts in rat fertility
control. Our passion is to create a healthy environment by better
controlling rat pest populations. We keep an inescapable truth in
mind. Two rats and their descendants can be responsible for the
birth of up to 15,000 pups after a year. We invented ContraPest,
the only U.S. EPA registered contraceptive for male and female
rats. ContraPest fits seamlessly into all integrated pest
management programs, greatly improving the overall goal of
effective rat management. We strive for clean cities, efficient
businesses, and happy households – with a product that was designed
to be effective and sustainable without killing rats. At
SenesTech, we are committed to improving the health of the world by
humanely managing animal populations through fertility control.
For more information visit https://senestech.com/ and
https://contrapeststore.com.
Safe Harbor Statement
This press release contains
"forward-looking statements" within the meaning of federal
securities laws, and we intend that such forward-looking statements
be subject to the safe harbor created thereby. Such forward-looking
statements include, among others, our belief that the surge of
acceptance of ContraPest will be key to building on our growth
trend and even accelerating it in 2023. Forward-looking statements
may describe future expectations, plans, results or strategies and
are often, but not always, made through the use of words such as
"believe," "may," "future," "plan," "will," "should," "expect,"
"anticipate," "eventually," "project," "estimate," "continuing,"
"intend" and similar words or phrases. You are cautioned that such
statements are subject to risks, uncertainties and other factors
that could cause actual results to differ materially from those
reflected by such forward-looking statements. Such factors include,
among others, the impacts and implications of the COVID-19
pandemic, the successful commercialization of our products, market
acceptance of our products, regulatory approval and regulation of
our products and other factors and risks identified from time to
time in our filings with the Securities and Exchange Commission,
including our Annual Report on Form 10-K for the fiscal year ended
December 31, 2021, our Registration
Statement on Form S-1, filed with the Securities and Exchange
Commission on October 24, 2022, as
amended on November 15, 2022, and the
final prospectus related thereto. All forward-looking statements
contained in this press release speak only as of the date on which
they were made and are based on management's assumptions and
estimates as of such date. Except as required by law, we do not
undertake any obligation to publicly update any forward-looking
statements, whether as a result of the receipt of new information,
the occurrence of future events or otherwise.
CONTACT:
Investors: Robert Blum, Joe
Dorame, Joe Diaz, Lytham Partners, LLC,
602-889-9700, senestech@lythampartners.com
Press: Nicole Williams, Chief
Revenue Officer, SenesTech, Inc., 928-779-4143
Company: Tom Chesterman, Chief Financial Officer,
SenesTech, Inc.,
928-779-4143
View original content to download
multimedia:https://www.prnewswire.com/news-releases/contrapest-success-stories-reported-at-vertebrate-pest-conference-301757275.html
SOURCE SenesTech, Inc.